Activity value 62tanzania Buyer,Last transaction date:
2024-01-21
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for the director general medical stores from 2023 to 2024.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2024, the company has completed 1 transactions, with a transaction quantity of 0 and a transaction weight of 283.16.
YearTransactionsQuantityWeight
2023000
202410283.16
Bill of lading data
<
1/15
>
Trade date
2024/01/21
B/L No.
62601
Suppliers
square pharmaceuticals plc. changed
Buyers
the director general medical stores
POLs
dhaka
PODs
——
Supply area
Bangladesh
Purchas area
Tanzania
Weight
283.16kg
Amount
5119406.42
Hs code
30049099
Product tags
medicine,clot
Product description
MEDICINE = 15731 PACKS, CLOTINEX 40 INJ
Expand
Trade date
2021/11/25
B/L No.
——
Suppliers
axa parenterals ltd.
Buyers
the director general medical stores
POLs
tuglakabad icd intkd6
PODs
dar es salaam
Supply area
India
Purchas area
Tanzania
Weight
——
Amount
339.536
Hs code
30049099
Product tags
paracetamol,axapara
Product description
AXAPARA - 100 ML (PARACETAMOL INT.INF
Expand
Trade date
2021/11/25
B/L No.
——
Suppliers
axa parenterals ltd.
Buyers
the director general medical stores
the director general medical stores is tanzania Buyer,
and primarily engages in the import and export business of products such as medicine,clot.
According to the 52wmb.com global trade database, as of 2024-01-21, the company has completed 90 international trades,
with its main trading regions covering india,bangladesh etc.
The core products include HS30049099 etc,
often transported via dar es salaam etc,
and its main trading partners are bdh industries inc.,axa parenterals ltd.,square pharmaceuticals plc. changed.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on the director general medical stores is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.